Pure Global AI
NCT05644028Recruiting

A Pilot Study of a Blended Intervention Targeting Emotion Dysregulation in Adults With ADHD

University of BergenClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Attention Deficit Hyperactivity Disorder
Drug/Device/Intervention
Emotion Regulation Intervention for ADHD
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Bergen
Location
Bergen, Norway
Timeline & enrollment
Phase
N/A
Start date
Nov 29, 2022
End date
Mar 15, 2023
Enrollment
16 participants
Primary outcome

The Credibility and Expectancy Questionnaire (CEQ),Open questions on treatment satisfaction,Treatment adherence

Summary

The current study aims to investigate the feasibility and preliminary clinical effects of a
 blended psychological intervention targeting emotion dysregulation in adults with ADHD.

ICD-10 classifications
Neurotic disorder, unspecifiedHyperkinetic disorder, unspecifiedHabit and impulse disorder, unspecifiedMild cognitive disorderDisturbance of activity and attention
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05644028
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05644028 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Bergen and is currently Recruiting. The study focuses on Attention Deficit Hyperactivity Disorder. Target enrollment is 16 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.